Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05057988 · ClinicalTrials.gov registry record · NA
Virtual Empowered Relief for Chronic Pain
A NA study of Pain and Chronic Pain, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 1
- Study location
NCT05057988: Completed NA study of Pain and Chronic Pain, sponsored by Stanford University.
NCT05057988 is a NA study of Pain and Chronic Pain that has completed, run by Stanford University. The registered enrollment target is 73 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05057988, a NA study of Pain and Chronic Pain, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the current pilot study is to examine a feasibility and the preliminary efficacy of Empowered Relief (ER) class when it is delivered 'virtually' to patients with chronic pain who take methadone or buprenorphine. The ER class is a single-session pain management class, which has demonstrated to be effective in improving pain and pain-related distress in patients with chronic low back pain, but its efficacy has not been examined in patients with chronic pain who take methadone or buprenorphine. Class participants will learn self-regulatory skills and develop a personalized plan to use the skills every day. The current study will examine a feasibility and participant's perception and satisfaction of this class at post-class. The study will also follow participants 3 months by administering 5 surveys (baseline, 2 weeks and 1 month, 2 months, and 3 months post-treatment) to determine whether the class confers the short-term and medium-term benefits across various aspects of health.
Primary Outcome
How useful was the information presented in the class? (a single item, 0-10 scale, higher scores correspond to greater perceived usefulness).
Conditions Studied
Interventions
- BEHAVIORAL Empowered Relief class
Study Locations (1)
California
- Stanford Pain Relief Innovations Lab - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2021-09-08 |
| Est. Completion | 2024-02-02 |
| Phase | NA |
What the finished NCT05057988 record still lists
NCT05057988 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Empowered Relief class is the first listed.
NCT05057988 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05057988 about?
NCT05057988 is a clinical study titled "Virtual Empowered Relief for Chronic Pain". The purpose of the current pilot study is to examine a feasibility and the preliminary efficacy of Empowered Relief (ER) class when it is delivered 'virtually' to patients with chronic pain who take methadone or buprenorphine. The ER class is a single-session pain management class, which has demonst...
What is the current status of trial NCT05057988?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2021-09-08. Estimated completion is 2024-02-02.
What conditions does trial NCT05057988 study?
This clinical trial studies the following conditions: Pain, Chronic Pain.
What interventions are being tested in trial NCT05057988?
The interventions under investigation include: Empowered Relief class (BEHAVIORAL).
Who is sponsoring clinical trial NCT05057988?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05057988 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05057988's enrollment target sits among peer trials
73 211th of 374 higher than 163 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI